A Clinical Study for People with Moderate to Severe Hidradenitis Suppurativa

Painful hidradenitis suppurativa breakouts happen in places you don't want to talk about.

That's why you should talk to us.

We're conducting a clinical study evaluating an investigational drug (avacopan) designed to potentially target the source of moderate to severe hidradenitis suppurativa, or acne inversa - with the hope of contributing to new scientific discovery.

SEE IF YOU PREQUALIFY

18 YEARS OF AGE
or older

DIAGNOSED WITH
hidradenitis suppurativa (acne inversa)

NO COST
to participate

Evaluating a targeted approach
to managing hidradenitis suppurativa.

Hidradenitis suppurativa, or acne inversa, can start off as small bumps or pimples in areas like your armpit or groin. As this skin disease becomes more severe, these bumps grow deeper, become painful, and can rupture or leak. That's why the Aurora Study is being conducted. It's evaluating an investigational drug (avacopan) designed to potentially target the source of this painful condition.

Study participation will last 44 weeks, and all eligible
participants will receive the following at no cost:

  • All study-related medications
  • All study-related care and monitoring
  • All study-related visits with our team of medical professionals
SEE IF YOU PREQUALIFY

Can I participate in this clinical study?

To participate in this clinical study, you must:

Be 18 years of
age or older

Be diagnosed with hidradenitis
suppurativa (acne inversa)

Have hidradenitis
suppurativa lesions
present in two distinct
areas of your body

See if you may be eligible to participate.

If you are living with hidradenitis suppurativa and are looking for a different way to manage this painful condition, consider participating in the Aurora Study. To see if you prequalify, please take this brief questionnaire.